In The Media

Scientists Giving New Hope to People With Spinal Cord Injuries

Breakthrough Israeli Technology for Spinal Cord Injuries (Hebrew)

NurExone completes another funding round as part of its preparation for clinical trials. (Hebrew)

Israeli company NurExone completes an additional investment round of 1.3 million Canadian dollars. (Hebrew)

Great professional analysis report has been published!

Our R&D group trained on the prestigious Zeta view TWIN laser system

Great talk by NurExone Biologic's Co-Founder and Chief Scientific Advisor, Prof. Shulamit Levenberg at the FemTech Expo

Congratulations to NurExone Biologic's Co-Founder and Chief Scientific Advisor, Prof. Shulamit Levenberg for her achievement of being inducted into the esteemed AIMBE College of Fellows

Fascinating presentation by our R&D Director Lyora Aharonov at the Weizman Institute of Science!

Giving with love